Second Clinic of Otolaryngology Head and Neck Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey.
Laryngoscope. 2012 Apr;122(4):741-6. doi: 10.1002/lary.23207. Epub 2012 Feb 28.
OBJECTIVES/HYPOTHESIS: To investigate the histologic consequences of simultaneous nasal glucocorticosteroid and xylometazoline HCl administration in the rabbit nasal mucosa.
Prospective randomized study.
Twenty New Zealand male rabbits were randomly placed into three groups: group I, control (n = 6); group II, xylometazoline HCl (n = 8); or group III, xylometazoline HCl-fluticasone furoate (n = 6). Group I received no treatment. Groups II and III received two intranasal puffs of xylometazoline HCl 0.5 mg/mL twice daily or two puffs of xylometazoline HCl 0.5 mg/mL twice daily plus one puff of 27.5 μg fluticasone furoate twice daily to each nostril (110 μg), respectively. At the end of 3 weeks, the rabbits were sacrificed. The mucosa of the nasal cavities was excised. Specimen sections (5 μm) were stained with hematoxylin and eosin, mucicarmine, and Gomori one-step trichrome and were examined under a light microscope. The presence of edema, congestion, inflammatory cell infiltration, nasociliary loss, epithelial and nerve-ending degeneration, and goblet cell increase were evaluated semiquantitatively (grades 0-3).
Statistically significant differences were detected between groups II and III in terms of edema, congestion, inflammatory cell infiltration, nasociliary loss, and epithelial degeneration (P = .006, P = .049, P = .015, P = .014, and P = .049, respectively). Nerve-ending degeneration, goblet cell increase, and quantitative goblet and neutrophil cell counts did not yield statistically significant differences between groups II and III (P = .137, P = .580, P = .770, and P = .616, respectively).
The combined simultaneous intranasal administration of xylometazoline HCl and fluticasone furoate appears to be beneficial in minimizing the long-term usage-associated congestion, edema, inflammatory cell infiltration, epithelial degeneration, and nasociliary loss in the rabbit model nasal mucosa.
目的/假设:研究同时给予鼻腔糖皮质激素和盐酸羟甲唑啉对兔鼻黏膜的组织学影响。
前瞻性随机研究。
将 20 只新西兰雄性兔随机分为三组:I 组,对照组(n = 6);II 组,盐酸羟甲唑啉(n = 8);或 III 组,盐酸羟甲唑啉-糠酸氟替卡松(n = 6)。I 组未接受任何治疗。II 组和 III 组分别每日两次向每侧鼻腔各喷入 0.5 mg/mL 盐酸羟甲唑啉两喷或每日两次向每侧鼻腔各喷入 0.5 mg/mL 盐酸羟甲唑啉两喷加每日两次向每侧鼻腔各喷入 27.5 μg 糠酸氟替卡松一喷(共 110 μg)。3 周后,处死兔子。切除鼻腔黏膜。用苏木精和伊红、粘卡红、Gomori 一步三色染色法对标本切片(5 μm)进行染色,在光镜下进行检查。评估水肿、充血、炎症细胞浸润、鼻纤毛丧失、上皮和神经末梢变性以及杯状细胞增生的存在情况,并进行半定量评估(0-3 级)。
II 组和 III 组在水肿、充血、炎症细胞浸润、鼻纤毛丧失和上皮变性方面存在统计学显著差异(P =.006,P =.049,P =.015,P =.014 和 P =.049)。神经末梢变性、杯状细胞增生以及定量杯状细胞和中性粒细胞计数在 II 组和 III 组之间无统计学显著差异(P =.137,P =.580,P =.770 和 P =.616)。
在兔鼻黏膜模型中,同时鼻内给予盐酸羟甲唑啉和糠酸氟替卡松似乎有利于最大限度地减少长期使用相关的充血、水肿、炎症细胞浸润、上皮变性和鼻纤毛丧失。